Goki Suda

48PUBLICATIONS

88CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersSport and exercise nutritionGastroenterology and hepatology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (48)

Sort by Publication Date:

|Jul 06, 2026

Circulating cfDNA CD86 methylation is associated with durable response to atezolizumab-bevacizumab in hepatocellular carcinoma.

|Jun 26, 2026

Alcohol involvement may modify the association between previous hepatitis B virus infection and hepatocellular carcinoma risk in steatotic liver disease.

|May 06, 2026

Prevalence and Prognostic Impact of the Coexistence of Cachexia and Sarcopenia in Patients With Chronic Liver Diseases.

|Dec 29, 2025

Cachexia in Cirrhosis Is Characterized by Sex-Specific Loss of Muscle Mass and Adipose Tissue.

Takao Miwa, Goki Suda, Ryosuke Tateishi

|Dec 13, 2025

Soluble Cluster of Differentiation 14 as a Prognostic Marker in Decompensated Cirrhosis With Water Retention.

Masato Nakai, Masatsugu Ohara, Daisuke Yokoyama

|Nov 21, 2025

Efficacy and Safety of Lenvatinib Versus Sorafenib in Recurrent HCC After Liver Transplant: A Multi-Center Real-World Study.

Federica Lo Prinzi, Federico Rossari, Antonio De Rosa

Pageof 8

Frequent Collaborators

18 joint publications

Naoki Kawagishi

14 joint publications

Kenichi Morikawa

Koji Ogawa

Naoya Sakamoto

Masatsugu Ohara

Hidenori Toyoda

Shigeo Shimose

Ryosuke Tateishi

Masatoshi Kudo

Hayato Hikita

Frequent Collaborators

18 joint publications

Naoki Kawagishi

14 joint publications

Kenichi Morikawa

5 joint publications

Koji Ogawa

5 joint publications

Naoya Sakamoto